Appendix 1. Incidence studies for Parkinson’s disease other than those reporting results by
age group.
Cockerell OC, Goodridge DM, Brodie D, Sander JW, Shorvon SD. Neurological disease
in a defined population: the results of a pilot study in two general practices.
Neuroepidemiology 1996, 15: 73-82.
Harada H, Nishikawa S, Takahashi K. Epidemiology of Parkinson's disease in a Japanese
city. Arch Neurol 1983, 40: 151-154.
Hofman A, Collette HJ, Bartelds AI. Incidence and risk factors of Parkinson's disease in
The Netherlands. Neuroepidemiology 1989, 8: 296-299.
Jenkins AC. Epidemiology of parkinsonism in Victoria. Med J Aust 1966, 2: 496-502.
Kuopio AM, Marttila RJ, Helenius H, Rinne UK. Changing epidemiology of Parkinson's
disease in southwestern Finland. Neurology 1999, 52: 302-308.
Kusumi M, Nakashima K, Harada H, Nakayama H, Takahashi K. Epidemiology of
Parkinson's disease in Yonago City, Japan: comparison with a study carried out 12 years
ago. Neuroepidemiology 1996, 15: 201-207.
Mehta P, Kifley A, Wang JJ, Rochtchina E, Mitchell P, Sue CM. Population prevalence
and incidence of Parkinson's disease in an Australian community. Intern Med J 2007, 37:
812-814.
Rajput AH, Offord KP, Beard CM, Kurland LT. Epidemiology of parkinsonism:
incidence, classification, and mortality. Ann Neurol 1984, 16: 278-282.
Rosati G, Granieri E, Pinna L, Aiello I, De Bastiani P, Tola R, Pirisi A. Parkinson's
disease. Prevalence and incidence in the Province of Sassari, North Sardinia. Acta Neurol
(Napoli) 1978, 33: 201-207.
Rosati G, Granieri E, Pinna L, Aiello I, Tola R, De Bastiani P, Pirisi A, Devoto MC. The
risk of Parkinson disease in Mediterranean people. Neurology 1980, 30: 250-255.
Schneider MG, Shardell M. Parkinson's disease and functional decline in older Mexican
Americans. Parkinsonism Relat Disord 2008, 14: 397-406.
Sutcliffe RL, Meara JR. Parkinson's disease epidemiology in the Northampton District,
England, 1992. Acta Neurol Scand 1995, 92: 443-450.
van de Vijver DA, Roos RA, Jansen PA, Porsius AJ, de Boer A. Estimation of incidence
and prevalence of Parkinson's disease in the elderly using pharmacy records.
Pharmacoepidemiol Drug Saf 2001, 10: 549-554.
Wermuth L, Bech S, Petersen MS, Joensen P, Weihe P, Grandjean P. Prevalence and
incidence of Parkinson's disease in The Faroe Islands. Acta Neurol Scand 2008, 118:
126-131.
Appendix 2. Prevalence studies for Parkinson’s disease other than those using door-to-door
ascertainment.
Anca M, Paleacu D, Shabtai H, Giladi N. Cross-sectional study of the prevalence of
Parkinson's disease in the Kibbutz movement in Israel. Neuroepidemiology 2002, 21: 5055.
Ashok PP, Radhakrishnan K, Sridharan R, Mousa ME. Epidemiology of Parkinson's
disease in Benghazi, North-East Libya. Clin Neurol Neurosurg 1986, 88: 109-113.
Attia Romdhane N, Ben Hamida M, Mrabet A, Larnaout A, Samoud S, Ben Hamda A,
Ben Hamda M, Oueslati S. Prevalence study of neurologic disorders in Kelibia (Tunisia).
Neuroepidemiology 1993, 12: 285-299.
Beghi E, Monticelli ML, Sessa A, Simone P. The prevalence of parkinsonism in Italy: an
epidemiological survey of the disease in general practice. The Italian General Practitioner
Study Group (IGPSG). Mov Disord 1994, 9: 403-408.
Bharucha NE, Bharucha EP, Bharucha AE, Bhise AV, Schoenberg BS. Prevalence of
Parkinson's disease in the Parsi community of Bombay, India. Arch Neurol 1988, 45:
1321-1323.
Brewis M, Poskanzer DC, Rolland C, Miller H. Neurological disease in an English city.
Acta Neurol Scand 1966, 42: Suppl 24:21-89.
Casetta I, Granieri E, Govoni V, Tola MR, Paolino E, Monetti VC, Caniatti L.
Epidemiology of Parkinson's disease in Italy. A descriptive survey in the U.S.L. of Cento,
province of Ferrara, Emilia-Romagna. Acta Neurol (Napoli) 1990, 12: 284-291.
Chio A, Magnani C, Schiffer D. Prevalence of Parkinson's disease in Northwestern Italy:
comparison of tracer methodology and clinical ascertainment of cases. Mov Disord 1998,
13: 400-405.
Chouza C, Ketzoian C, Caamano JL, Caceres R, Coirolo G, Dieguez E, Rega I.
Prevalence of Parkinson's disease in a population of Uruguay. Preliminary results. Adv
Neurol 1996, 69: 13-17.
Claveria LE, Duarte J, Sevillano MD, Perez-Sempere A, Cabezas C, Rodriguez F, de
Pedro-Cuesta J. Prevalence of Parkinson's disease in Cantalejo, Spain: a door-to-door
survey. Mov Disord 2002, 17: 242-249.
D'Alessandro R, Gamberini G, Granieri E, Benassi G, Naccarato S, Manzaroli D.
Prevalence of Parkinson's disease in the Republic of San Marino. Neurology 1987, 37:
1679-1682.
Dias JA, Felgueiras MM, Sanchez JP, Goncalves JM, Falcao JM, Pimenta ZP. The
prevalence of Parkinson's disease in Portugal. A population approach. Eur J Epidemiol
1994, 10: 763-767.
Errea JM, Ara JR, Aibar C, de Pedro-Cuesta J. Prevalence of Parkinson's disease in lower
Aragon, Spain. Mov Disord 1999, 14: 596-604.
Fall PA, Axelson O, Fredriksson M, Hansson G, Lindvall B, Olsson JE, Granerus AK.
Age-standardized incidence and prevalence of Parkinson's disease in a Swedish
community. J Clin Epidemiol 1996, 49: 637-641.
Govoni V, Granieri E, Tola MR, Casetta I, Monetti VC, Fainardi E, Paolino E.
Prevalence of anti-parkinson drugs' use in Ferrara, northern Italy, 1988. Acta Neurol
Scand 1994, 89: 433-438.
Hobson P, Gallacher J, Meara J. Cross-sectional survey of Parkinson's disease and
parkinsonism in a rural area of the United Kingdom. Mov Disord 2005, 20: 995-998.
Kessler, II. Epidemiologic studies of Parkinson's disease. II. A hospital-based survey. Am
J Epidemiol 1972, 95: 308-318.
Kuopio AM, Marttila RJ, Helenius H, Rinne UK. Changing epidemiology of Parkinson's
disease in southwestern Finland. Neurology 1999, 52: 302-308.
Kusumi M, Nakashima K, Harada H, Nakayama H, Takahashi K. Epidemiology of
Parkinson's disease in Yonago City, Japan: comparison with a study carried out 12 years
ago. Neuroepidemiology 1996, 15: 201-207.
Lai BC, Schulzer M, Marion S, Teschke K, Tsui JK. The prevalence of Parkinson's
disease in British Columbia, Canada, estimated by using drug tracer methodology.
Parkinsonism Relat Disord 2003, 9: 233-238.
Lombard A, Gelfand M. Parkinson's disease in the African. Cent Afr J Med 1978, 24: 58.
Marttila RJ, Rinne UK. Epidemiology of Parkinson's disease in Finland. Acta Neurol
Scand 1976, 53: 81-102.
Mayeux R, Marder K, Cote LJ, Denaro J, Hemenegildo N, Mejia H, Tang MX, Lantigua
R, Wilder D, Gurland B, et al. The frequency of idiopathic Parkinson's disease by age,
ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol 1995, 142:
820-827.
Mehta P, Kifley A, Wang JJ, Rochtchina E, Mitchell P, Sue CM. Population prevalence
and incidence of Parkinson's disease in an Australian community. Intern Med J 2007, 37:
812-814.
Menniti-Ippolito F, Spila-Alegiani S, Vanacore N, Bonifati V, Diana G, Meco G,
Raschetti R. Estimate of parkinsonism prevalence through drug prescription histories in
the Province of Rome, Italy. Acta Neurol Scand 1995, 92: 49-54.
Moriwaka F, Tashiro K, Itoh K, Honma S, Okumura H, Kikuchi S, Hamada T, Kaneko S,
Kurokawa Y. Prevalence of Parkinson's disease in Hokkaido, the northernmost island of
Japan. Intern Med 1996, 35: 276-279.
Mutch WJ, Dingwall-Fordyce I, Downie AW, Paterson JG, Roy SK. Parkinson's disease
in a Scottish city. Br Med J (Clin Res Ed) 1986, 292: 534-536.
Osuntokun BO, Adeuja AO, Schoenberg BS, Bademosi O, Nottidge VA, Olumide AO,
Ige O, Yaria F, Bolis CL. Neurological disorders in Nigerian Africans: a communitybased study. Acta Neurol Scand 1987, 75: 13-21.
Paddison RM, Griffith RP. Occurrence of Parkinson's disease in black patients at Charity
Hospital in New Orleans. Neurology 1974, 24: 688-690.
Peters CM, Gartner CE, Silburn PA, Mellick GD. Prevalence of Parkinson's disease in
metropolitan and rural Queensland: a general practice survey. J Clin Neurosci 2006, 13:
343-348.
Porter B, Macfarlane R, Unwin N, Walker R. The prevalence of Parkinson's disease in an
area of North Tyneside in the North-East of England. Neuroepidemiology 2006, 26: 156161.
Rosati G, Granieri E, Pinna L, Aiello I, De Bastiani P, Tola R, Pirisi A. Parkinson's
disease. Prevalence and incidence in the Province of Sassari, North Sardinia. Acta Neurol
(Napoli) 1978, 33: 201-207.
Rosati G, Granieri E, Pinna L, Aiello I, Tola R, De Bastiani P, Pirisi A, Devoto MC. The
risk of Parkinson disease in Mediterranean people. Neurology 1980, 30: 250-255.
Rosati G, Granieri E, Pinna L, Devoto MC. The frequency of Parkinson's disease in the
Province of Nuoro (Sardinia). Acta Neurol (Napoli) 1979, 1: 303-308.
Sanchez JL, Buritica O, Pineda D, Uribe CS, Palacio LG. Prevalence of Parkinson's
disease and parkinsonism in a Colombian population using the capture-recapture method.
Int J Neurosci 2004, 114: 175-182.
Schneider MG, Shardell M. Parkinson's disease and functional decline in older Mexican
Americans. Parkinsonism Relat Disord 2008, 14: 397-406.
Schoenberg BS, Osuntokun BO, Adeuja AO, Bademosi O, Nottidge V, Anderson DW,
Haerer AF. Comparison of the prevalence of Parkinson's disease in black populations in
the rural United States and in rural Nigeria: door-to-door community studies. Neurology
1988, 38: 645-646.
Schrag A, Ben-Shlomo Y, Quinn NP. Cross sectional prevalence survey of idiopathic
Parkinson's disease and Parkinsonism in London. Bmj 2000, 321: 21-22.
Snow B, Wiens M, Hertzman C, Calne D. A community survey of Parkinson's disease.
Cmaj 1989, 141: 418-422.
Strickland D, Bertoni JM. Parkinson's prevalence estimated by a state registry. Mov
Disord 2004, 19: 318-323.
Sutcliffe RL, Meara JR. Parkinson's disease epidemiology in the Northampton District,
England, 1992. Acta Neurol Scand 1995, 92: 443-450.
Sutcliffe RL, Prior R, Mawby B, McQuillan WJ. Parkinson's disease in the district of the
Northampton Health Authority, United Kingdom. A study of prevalence and disability.
Acta Neurol Scand 1985, 72: 363-379.
Svenson LW, Platt GH, Woodhead SE. Geographic variations in the prevalence rates of
Parkinson's disease in Alberta. Can J Neurol Sci 1993, 20: 307-311.
Taba P, Asser T. Prevalence of Parkinson's disease in Estonia. Acta Neurol Scand 2002,
106: 276-281.
Tandberg E, Larsen JP, Nessler EG, Riise T, Aarli JA. The epidemiology of Parkinson's
disease in the county of Rogaland, Norway. Mov Disord 1995, 10: 541-549.
Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, Mayeux R, Langston JW.
Parkinson disease in twins: an etiologic study. Jama 1999, 281: 341-346.
Tekle-Haimanot R, Abebe M, Gebre-Mariam A, Forsgren L, Heijbel J, Holmgren G,
Ekstedt J. Community-based study of neurological disorders in rural central Ethiopia.
Neuroepidemiology 1990, 9: 263-277.
Totaro R, Marini C, Pistoia F, Sacco S, Russo T, Carolei A. Prevalence of Parkinson's
disease in the L'Aquila district, central Italy. Acta Neurol Scand 2005, 112: 24-28.
Trenkwalder C, Schwarz J, Gebhard J, Ruland D, Trenkwalder P, Hense HW, Oertel
WH. Starnberg trial on epidemiology of Parkinsonism and hypertension in the elderly.
Prevalence of Parkinson's disease and related disorders assessed by a door-to-door survey
of inhabitants older than 65 years. Arch Neurol 1995, 52: 1017-1022.
van de Vijver DA, Roos RA, Jansen PA, Porsius AJ, de Boer A. Estimation of incidence
and prevalence of Parkinson's disease in the elderly using pharmacy records.
Pharmacoepidemiol Drug Saf 2001, 10: 549-554.
Wermuth L, Bech S, Petersen MS, Joensen P, Weihe P, Grandjean P. Prevalence and
incidence of Parkinson's disease in The Faroe Islands. Acta Neurol Scand 2008, 118:
126-131.
Wermuth L, Joensen P, Bunger N, Jeune B. High prevalence of Parkinson's disease in the
Faroe Islands. Neurology 1997, 49: 426-432.
Wermuth L, Pakkenberg H, Jeune B. High age-adjusted prevalence of Parkinson's disease
among Inuits in Greenland. Neurology 2002, 58: 1422-1425.
Wermuth L, Pakkenberg H, Jeune B. High age-adjusted prevalence of Parkinson's disease
among Inuit in Greenland. Int J Circumpolar Health 2004, 63 Suppl 2: 369-370.
Wermuth L, von Weitzel-Mudersbach P, Jeune B. A two-fold difference in the ageadjusted prevalences of Parkinson's disease between the island of Als and the Faroe
Islands. Eur J Neurol 2000, 7: 655-660.
Woo J, Lau E, Ziea E, Chan DK. Prevalence of Parkinson's disease in a Chinese
population. Acta Neurol Scand 2004, 109: 228-231.
Supplemental table 1. Exposure to pesticides in general in relation to Parkinson’s disease.
Supplemental table 2. Exposure to herbicides in relation to Parkinson’s disease.
Supplemental table 3. Exposure to insecticides in relation to Parkinson’s disease.
Supplemental table 4. Exposure to fungicides in relation to Parkinsons’ disease.